Ternary Therapeutics targets “undruggable” proteins with AI-designed molecular glues, raising €4.1 million
London-based Ternary Therapeutics has secured €4.1 million in seed funding to advance its AI platform for designing novel medicines, specifically targeting "undruggable" proteins with molecular glues. This development signifies a crucial step in democratizing the drug discovery process, moving it from serendipitous findings to a more systematic, engineering-led approach. The funding round, led by European venture firm daphni, underscores growing investor confidence in AI-driven biomedical innovation across the continent. Ternary's platform uniquely integrates physics-informed artificial intelligence with rapid experimental validation. This fusion allows for the intentional engineering of molecular glues, a class of therapeutics capable of interacting with proteins previously considered beyond the reach of conventional drug development. By treating drug discovery as an engineering challenge, the company aims to significantly accelerate the identification and design of promising therapeutic candidates, thereby revolutionizing treatment possibilities for a range of diseases. The investment in Ternary Therapeutics is part of a broader European trend, with recent funding rounds bolstering companies like Sable Bio, Graph Therapeutics, and Scripta Therapeutics, all leveraging AI for drug discovery and safety prediction. This collective €21.8 million in funding over 2025-2026 highlights Europe's burgeoning role as a hub for AI-enabled biotech, fostering an environment where computational power and biological understanding converge to address complex medical challenges and enhance digital sovereignty in critical scientific sectors.
Curated and translated by Europe Digital for our multilingual European audience.
Source Information
European Alternatives You Might Like
Mangopay
Mangopay is a payment infrastructure provider specializing in payments for marketplaces and platforms. It offers virtual wallet technology for managing funds, enabling features such as split payments, multi-currency support, and KYC/AML compliance. Key functionalities include automated payouts, transaction monitoring, and customizable payment flows. This service is primarily aimed at businesses that manage marketplaces, crowdfunding platforms, and sharing economy models and require complex payment solutions. Mangopay distinguishes itself by offering a flexible and scalable payment solution specifically designed for platform-based business models, allowing them to control cash flows and streamline payment processes.
Scaleway
Scaleway is a European cloud computing provider offering a range of services, including servers, storage, and networking solutions. Key features include bare metal servers, virtual machines, object storage, and managed Kubernetes. It's suitable for developers, startups, and businesses seeking cloud infrastructure for web applications, data storage, and various other workloads. Scaleway distinguishes itself through competitive pricing and a focus on European data sovereignty, with data centers in France and the Netherlands.